Comgest Global Investors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$328M Sell
1,289,528
-54,703
-4% -$12.7M 7.21% 3
2026
Q1
$329M Sell
1,344,231
-309,702
-19% -$72.1M 7.16% 2
2025
Q4
$342M Sell
1,653,933
-164,767
-9% -$32.6M 6.1% 5
2025
Q3
$337M Sell
1,818,700
-251,012
-12% -$43M 5.97% 6
2025
Q2
$316M Sell
2,069,712
-89,108
-4% -$13.7M 5.39% 6
2025
Q1
$358M Buy
2,158,820
+57,917
+3% +$9.06M 6.39% 7
2024
Q4
$304M Buy
2,100,903
+3,714
+0.2% +$576K 4.98% 7
2024
Q3
$340M Buy
2,097,189
+109,235
+5% +$17.4M 4.87% 8
2024
Q2
$291M Buy
1,987,954
+127,133
+7% +$18.9M 3.99% 8
2024
Q1
$294M Buy
1,860,821
+44,207
+2% +$7.04M 4.1% 7
2023
Q4
$285M Buy
1,816,614
+5,585
+0.3% +$856K 4.27% 7
2023
Q3
$282M Buy
1,811,029
+86,404
+5% +$14.3M 4.83% 6
2023
Q2
$285M Sell
1,724,625
-20,113
-1% -$3.25M 4.77% 6
2023
Q1
$270M Sell
1,744,738
-90,943
-5% -$14.7M 5.07% 6
2022
Q4
$324M Buy
1,835,681
+359,176
+24% +$62M 7.16% 4
2022
Q3
$241M Buy
1,476,505
+33,997
+2% +$5.75M 5.31% 6
2022
Q2
$256M Buy
1,442,508
+98,501
+7% +$17.6M 5.03% 7
2022
Q1
$238M Sell
1,344,007
-97,110
-7% -$16.5M 3.72% 9
2021
Q4
$247M Buy
1,441,117
+38,080
+3% +$6.23M 3.28% 12
2021
Q3
$227M Buy
1,403,037
+51,014
+4% +$8.7M 2.97% 15
2021
Q2
$223M Sell
1,352,023
-164,670
-11% -$27.3M 3.03% 14
2021
Q1
$249M Buy
1,516,693
+94,964
+7% +$15.4M 3.82% 12
2020
Q4
$224M Buy
1,421,729
+70,845
+5% +$10.5M 3.93% 11
2020
Q3
$201M Buy
1,350,884
+10,350
+0.8% +$1.53M 3.01% 14
2020
Q2
$189M Sell
1,340,534
-48,422
-3% -$7.06M 3.16% 14
2020
Q1
$182M Sell
1,388,956
-141,144
-9% -$20M 3.72% 12
2019
Q4
$223M Sell
1,530,100
-17,300
-1% -$2.35M 4.03% 11
2019
Q3
$200M Buy
1,547,400
+92,800
+6% +$12.2M 4.08% 11
2019
Q2
$203M Sell
1,454,600
-187,600
-11% -$26M 4.4% 9
2019
Q1
$230M Buy
1,642,200
+150,400
+10% +$20.1M 5.03% 8
2018
Q4
$193M Buy
1,491,800
+840,100
+129% +$117M 4.76% 7
2018
Q3
$90M Buy
651,700
+514,500
+375% +$68.4M 2.02% 17
2018
Q2
$16.6M Buy
137,200
+16,800
+14% +$2.1M 0.37% 22
2018
Q1
$15.4M Buy
120,400
+9,300
+8% +$1.26M 0.34% 22
2017
Q4
$15.5M Buy
111,100
+74,500
+204% +$10.4M 0.34% 24
2017
Q3
$4.76M Buy
36,600
+8,700
+31% +$1.15M 0.11% 39
2017
Q2
$3.69M Hold
27,900
0.09% 40
2017
Q1
$3.47M Sell
27,900
-904,750
-97% -$108M 0.09% 41
2016
Q4
$107M Sell
932,650
-59,200
-6% -$6.84M 3.49% 9
2016
Q3
$117M Sell
991,850
-180,100
-15% -$21.8M 3.49% 10
2016
Q2
$142M Buy
1,171,950
+23,900
+2% +$2.72M 4.32% 9
2016
Q1
$124M Buy
1,148,050
+318,300
+38% +$33M 4.23% 10
2015
Q4
$85.2M Buy
829,750
+114,510
+16% +$11.5M 2.84% 12
2015
Q3
$66.8M Buy
715,240
+48,000
+7% +$4.64M 2.53% 12
2015
Q2
$65M Sell
667,240
-9,400
-1% -$941K 2.16% 13
2015
Q1
$68.1M Sell
676,640
-174,100
-20% -$17.7M 2.12% 13
2014
Q4
$89M Buy
+850,740
New +$89.7M 2.72% 11

Other funds holding JNJ

Comgest Global Investors's JNJ Position: Q2 2026 in Review

Comgest Global Investors reduced its Johnson & Johnson (JNJ) stake by 4.1% in Q2 2026, selling an estimated $12.7M and leaving 1,289,528 shares worth $328M. The position accounts for 7.21% of the portfolio, ranked #3.

Comgest Global Investors first reported a position in JNJ in Q4 2014 and has held it in 47 quarters since. The position peaked at $358M in Q1 2025. 2,122 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Comgest Global Investors held 1,289,528 shares of Johnson & Johnson worth $328M as of Q2 2026.
  • Comgest Global Investors sold 54,703 Johnson & Johnson shares in Q2 2026, an estimated $12.7M.
  • Johnson & Johnson made up 7.21% of Comgest Global Investors's portfolio in Q2 2026, its #3 holding.
  • Comgest Global Investors first reported a position in Johnson & Johnson in Q4 2014 and has held it in 47 quarters since.
  • Comgest Global Investors's Johnson & Johnson position peaked at $358M in Q1 2025.
  • 2,122 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Comgest Global Investors's 13F filing for Q2 2026, filed 24 Jul 2026.